Cochlear Launches Nucleus® Nexa® System and Baha® 7 Sound Processor

Cochlear Launches Nucleus® Nexa® System and Baha® 7 Sound Processor | Message from the President

At Cochlear, innovation isn’t just a buzzword, it’s part of our mission, and this past quarter we were proud to introduce major advancements that are reshaping what’s possible in hearing technology: the Nucleus® Nexa® System, the Baha® 7 Sound Processor and Baha SoundBand™ as well as the new Kanso® 3 Sound Processor.

Introducing the Nucleus Nexa System

The Nucleus Nexa System marks a new chapter in cochlear implants. It’s the world’s first smart cochlear implant system. The new Nexa Implant is built to support future enhancements with upgradeable firmware and internal memory.* Paired with our most advanced sound processors, the Nucleus 8 Nexa and Kanso 3 Nexa, users get a hearing experience that’s intelligent, adaptive, and incredibly lightweight. Whether navigating a noisy street or enjoying a quiet conversation, the Nexa System adjusts in real time to deliver clarity and comfort.

The Nucleus Nexa Implant and sound processors are supported by our ecosystem of tools to enable best patient care and outcomes including Nucleus SmartNav, Nucleus Smart App, Custom Sound® Pro fitting software and wireless accessories. In addition, those with our current Nucleus Systems will be able to upgrade to the new Kanso 3 Sound Processor.

We are excited for this system to become available in early September.

Meet the Baha 7 Sound Processor

On the bone conduction side, the Baha 7 Sound Processor is setting a new standard for connectivity and convenience. It’s the first processor to feature Bluetooth® LE Audio and Auracast™.** Our non-surgical Baha Start portfolio now includes the Baha 7 Sound Processor and the new Baha SoundBand. Compared to the Softband, the new SoundBand features a slimmer band with improved adjustability, a lower profile, moveable connector discs and more color options to help young children be as comfortable and confident as possible.

Real Stories, Real Impact

In Penfield, New York, first grader Lyla is thriving with her cochlear implant after being born with congenital cytomegalovirus (cCMV). Her mother, Kara, has become a passionate advocate for hearing health and early intervention. Read Lyla’s story.

As we look ahead, we remain focused on delivering smarter, more connected hearing solutions that grow with our users and empower clinicians.

Sincerely,
Lisa Aubert
President Cochlear North America

Disclaimer

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

The Bluetooth® and Auracast™ word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Cochlear is under license.

Auracast™ broadcast audio capability is subject to third party adoption of the Auracast protocol.

*As future advancements or technology become available for the CI1000 series implant, a firmware update may be required in order to take advantage of newer features.

**As Bluetooth LE Audio compatible devices become available, a sound processor firmware update will be required to use certain features.